TY  - GEN
AU  - Palmerini,Tullio
AU  - Della Riva,Diego
AU  - Benedetto,Umberto
AU  - Bacchi Reggiani,Letizia
AU  - Feres,Fausto
AU  - Abizaid,Alexandre
AU  - Gilard,Martine
AU  - Morice,Marie-Claude
AU  - Valgimigli,Marco
AU  - Hong,Myeong-Ki
AU  - Kim,Byeong-Keuk
AU  - Jang,Yangsoo
AU  - Kim,Hyo-Soo
AU  - Park,Kyung Woo
AU  - Colombo,Antonio
AU  - Chieffo,Alaide
AU  - Sangiorgi,Diego
AU  - Biondi-Zoccai,Giuseppe
AU  - Généreux,Philippe
AU  - Angelini,Gianni D
AU  - Pufulete,Maria
AU  - White,Jonathon
AU  - Bhatt,Deepak L
AU  - Stone,Gregg W
TI  - Three, six, or twelve months of dual antiplatelet therapy after DES implantation in patients with or without acute coronary syndromes: an individual patient data pairwise and network meta-analysis of six randomized trials and 11 473 patients
SN  - 1522-9645
PY  - 2017///1016
KW  - Acute Coronary Syndrome
KW  - mortality
KW  - Analysis of Variance
KW  - Aspirin
KW  - administration & dosage
KW  - Blood Vessel Prosthesis Implantation
KW  - methods
KW  - Clopidogrel
KW  - Coronary Artery Disease
KW  - Death, Sudden, Cardiac
KW  - epidemiology
KW  - Drug Administration Schedule
KW  - Drug Therapy, Combination
KW  - Drug-Eluting Stents
KW  - Female
KW  - Graft Occlusion, Vascular
KW  - etiology
KW  - Hemorrhage
KW  - chemically induced
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Myocardial Infarction
KW  - Myocardial Revascularization
KW  - Platelet Aggregation Inhibitors
KW  - Purinergic P2Y Receptor Antagonists
KW  - Randomized Controlled Trials as Topic
KW  - Risk Assessment
KW  - Stroke
KW  - Ticlopidine
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Meta-Analysis; Review
UR  - https://doi.org/10.1093/eurheartj/ehw627
ER  -